306 results on '"Kayagaki, Nobuhiko"'
Search Results
2. Cell death
3. Epigenetic and transcriptional control of gasdermins
4. Discovery of a caspase cleavage motif antibody reveals insights into noncanonical inflammasome function
5. NINJ1 mediates plasma membrane rupture during lytic cell death
6. Control of Cell Death in Health and Disease
7. Highly multiplexed, image-based pooled screens in primary cells and tissues with PerturbView
8. Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death
9. Polymorphism of Murine Fas Ligand that Affects the Biological Activity
10. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes
11. Does caspase-12 suppress inflammasome activation?
12. Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
13. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
14. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells
15. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis
16. DUBA: A Deubiquitinase That Regulates Type I Interferon Production
17. Dying cells fan the flames of inflammation
18. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases
19. Does caspase-12 suppress inflammasome activation?
20. Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection
21. Evolutionary loss of inflammasomes in the Carnivora and implications for the carriage of zoonotic infections
22. Selective activation of PFKL suppresses the phagocytic oxidative burst
23. Caspase-11: arming the guards against bacterial infection
24. Interleukin-22 Induces Interleukin-18 Expression from Epithelial Cells during Intestinal Infection
25. Phosphorylation of NLRC4 is critical for inflammasome activation
26. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1
27. Non-canonical inflammasome activation targets caspase-11
28. Evolutionary Loss of Inflammasomes in Carnivores to Facilitate Carriage of Zoonotic Infections
29. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
30. NINJ1 mediates plasma membrane rupture during lytic cell death
31. Rescue from a fiery death: A therapeutic endeavor
32. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus
33. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice
34. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome–positive leukemia cells
35. Involvement of TWEAK in Interferon γ-stimulated Monocyte Cytotoxicity
36. Selective Upregulation of Fibroblast Fas Ligand Expression, and Prolongation of Fas/Fas Ligand-Mediated Skin Allograft Survival, by Retinoic Acid: the Skin as a Retinoide-Inducible Immune Privilege Site
37. Functional Fas Ligand Expression in Thyrocytes from Patients with Graves’ Disease
38. Type I Interferons (IFNs) Regulate Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of Type I IFNs
39. A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation
40. Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
41. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
42. IRF2 transcriptionally induces GSDMD expression for pyroptosis
43. MCC950/CRID3 potently targets the NACHT domain of wildtype NLRP3 but not disease-associated mutants for inflammasome inhibition
44. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3
45. Soluble Fas (APO-1, CD95) and Soluble Fas Ligand in Rheumatic Diseases
46. Accumulation of Soluble Fas in Inflamed Joints of Patients with Rheumatoid Arthritis
47. CD95 ligand in graft rejection
48. INVOLVEMENT OF TRAIL/TRAIL-R INTERACTION IN IFN-α-INDUCED APOPTOSIS OF DAUDI B LYMPHOMA CELLS
49. TRAIL expression by activated human CD4+Vα24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells
50. Fas/Fas ligand-mediated apoptosis of murine Langerhans cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.